Cometriq

GlaxoSmithKline offloads royalty rights for 2 cancer drugs in $342M windfall it will use to finance consumer spinoff
Endpoints
Thu, 04/1/21 - 11:36 pm
GSK
Cabometyx
Cometriq
Royalty Pharma
Exelixis Gets FDA Approval for Cabometyx in Combination Therapy for Front-Line RCC
Motley Fool
Sat, 01/23/21 - 11:35 pm
Exelixis
FDA
Cabometyx
Cometriq
advanced renal cell carcinoma
Exelixis Hits Blockbuster Status
Motley Fool
Mon, 08/5/19 - 10:45 am
Exelixis
cabozantinib
Cabometx
kidney cancer
liver cancer
Cometriq
thyroid cancer
3 Things Exelixis Must Do to Survive and Thrive in 2017
Motley Fool
Thu, 11/17/16 - 04:43 pm
Exelixis
cabozantinib
Cabometyx
Cometriq
Kidney Cancer Drug Boxing Match
Motley Fool
Mon, 10/5/15 - 09:17 am
kidney cancer
Bristol-Myers Squibb
Novartis
Exelixis
Opdivo
Cometriq
Afinitor
Cometriq Plays Wallflower As Opdivo's Dance Card Fills
Seeking Alpha
Mon, 09/28/15 - 08:23 am
Bristol-Myers Squibb
Opdivo
Cometriq
Exelixis
kidney cancer
Novartis bullish on Afinitor cancer drug despite new competition
Yahoo/Reuters
Tue, 07/21/15 - 06:52 pm
Novartis
Afinitor
Opdivo
Cometriq
Exelixis
Bristol-Myers Squibb
Exelixis Drug Slows Kidney Cancer In New Chance For Embattled Biotech
Forbes
Mon, 07/20/15 - 09:07 am
Exelixis
kidney cancer
Cometriq
Exelixis to Investors: "Wait for It... No, Seriously, Wait for It!"
Motley Fool
Sun, 07/5/15 - 11:03 am
Exelixis
Cobimetinib
vemurafenib
Cometriq
Is This the Year Exelixis Excels?
Morningstar
Fri, 03/28/14 - 10:06 am
Exelixis
Cometriq
prostate cancer
An Excellent Investment in the Biotech Space?
Motley Fool
Sat, 09/21/13 - 10:08 am
Cometriq
medullary thyroid cancer
Exelixis
Will the Exelixis Hype Catch Up to Its Valuation?
Motley Fool
Tue, 09/17/13 - 11:04 am
Exelixis
Cometriq
medullary thyroid cancer
Exelixis Presents Cometriq (cabozantinib) Clinical Trial Data in Patients with Progressive, Metastatic Medullary Thyroid Cancer
Yahoo/BusinessWire
Sun, 06/2/13 - 11:41 am
Exelixis
Cometriq
thyroid cancer
medullary thyroid cancer
Tackling Cancer: Thyroid Cancer's Biggest Current and Upcoming Players
Motley Fool
Mon, 04/29/13 - 05:24 pm
thyroid cancer
Caprelsa
AstraZeneca
Cometriq
Exelixis
Nexavar
Bayer
ONYX Pharmaceuticals
Where Is Exelixis In The Cancer Therapeutics Market?
Seeking Alpha
Mon, 04/1/13 - 11:01 am
Exelixis
cabozantinib
Cometriq
cancer
JPMorgan Healthcare Conference Highlights: Exelixis
Motley Fool
Mon, 01/14/13 - 12:30 pm
Exelixis
JPMHC 2013
Cometriq
medullary thyroid cancer
Exelixis' Crowning Achievement
Motley Fool
Sat, 12/1/12 - 09:26 am
Exelixis
cabozantinib
Cometriq
thyroid cancer
medullary thyroid cancer
Exelixis Wins First Approval of Cancer Drug
Minyanville
Fri, 11/30/12 - 09:37 am
medullary thyroid cancer
Exelixis
Cometriq